Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis

A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders

Róbert Královics, Francesco Passamonti, Andreas Buser et al. · New England Journal of Medicine · 2005 · 3.5K citations · Full text

Life Sciences, Genetics, Hematology +15

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

E. Joanna Baxter, Linda M. Scott, Peter J. Campbell et al. · The Lancet · 2005 · 3.4K citations

Life Sciences, Genetics, Hematology +14

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

E. Joanna Baxter, Linda M. Scott, Peter J. Campbell et al. · The Lancet · 2005 · 1.1K citations

Life Sciences, Genetics, Hematology +14

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]

Brigitte Dupriez, Pierre Morel, JL Demory et al. · Blood · 1996 · 521 citations · Full text

Medicine, Oncology, Pathology +14

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]

Brigitte Dupriez, Pierre Morel, JL Demory et al. · Blood · 1996 · 407 citations · Full text

Medicine, Oncology, Pathology +14